Wan a read update without *update*:
biz.yahoo.com
Zenaca ZD1839 drug is featured with 8 abstracts at AACC-NCI conference. Pfizer didn't find necessary to submit single abstract on any program. Oh yes, this are *proprietary* information not available to mortal human.
Wish that they not only lose WL, but also Lipitor (without penny in royalty).
Dam PNU and day when they bought SUGN. Dam Freke with two face.
*Long Live OSIP*!
Miljenko
AstraZeneca Cancer Drug Shows Promise in Early Tests, WSJ Says
Washington, Nov. 17 (Bloomberg) -- AstraZeneca Plc has
developed a gene-based cancer treatment that shows promise in
reducing tumors in early studies, the Wall Street Journal Europe
reported, citing research presented at a Washington medical
conference. The drug, known as ZD1839 or Iressa, is designed to
block the EGF protein that helps stimulate cancer cells, the
newspaper said. Other companies, including Pfizer Inc. and
ImClone Systems Inc., are working on similar approaches to cancer
therapy, the paper said.
AstraZeneca, the world's biggest drugmaker, also sells
tamoxifen, which last year became the first drug approved by U.S.
regulators for reducing the risk of breast cancer. |
